This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Harold E. Alexander, MD
Los Cruces, NM

Kathleen McCarty, MD
Sherman Oaks, Calif

Martin B. Giffen, MD
University of Texas Health Science Center at San Antonio

JAMA. 1985;253(11):1557-1558.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We read Dr Burnakis' comments concerning our case report with interest. His point about propranolol not decreasing peripheral resistance is well taken. We are aware of the reported effects of propranolol and haloperidol that Dr Burnakis mentions in his letter. What is unique about our patient, we feel, is that she was treated with propranolol and haloperidol singly at different times without adverse effects, and only had the severe reactions we reported when she was given propranolol and haloperidol concurrently or in close temporal succession.

Perhaps Dr Burnakis is correct in stating that our proposed mechanism is erroneous. We suspect that the patient in our case report has a genetic susceptibility to this drug combination and is unique in this respect. We do not suggest that this drug combination not be used, but we do advise caution. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?